Free Trial

Charles River Associates (CRAI) Financials

Charles River Associates logo
$145.15 -0.56 (-0.38%)
Closing price 06/8/2026 04:00 PM Eastern
Extended Trading
$145.22 +0.07 (+0.05%)
As of 06/8/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Charles River Associates

Annual Income Statements for Charles River Associates

This table shows Charles River Associates' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Net Income / (Loss) Attributable to Common Shareholders
7.66 13 7.62 22 21 25 42 44 38 47 55
Consolidated Net Income / (Loss)
6.33 14 7.70 22 21 25 42 44 38 47 55
Net Income / (Loss) Continuing Operations
6.33 14 7.70 22 21 25 42 44 38 47 55
Total Pre-Tax Income
12 22 15 29 27 34 54 59 52 66 77
Total Operating Income
12 19 16 29 29 35 56 59 58 71 83
Total Gross Profit
96 97 111 128 134 138 166 181 184 207 752
Total Revenue
304 325 370 418 451 508 566 591 624 687 752
Operating Revenue
304 325 370 418 451 508 566 591 624 687 752
Total Cost of Revenue
208 227 259 289 318 371 400 410 440 480 0.00
Total Operating Expenses
84 78 95 100 104 103 110 122 127 137 668
Selling, General & Admin Expense
72 71 87 90 94 90 97 110 115 125 135
Depreciation Expense
6.55 7.90 8.95 10.00 11 13 13 12 12 12 14
Other Operating Expenses / (Income)
- - - - - - - - - - 519
Total Other Income / (Expense), net
-0.58 2.97 -0.63 -0.00 -2.55 -1.17 -1.46 0.06 -5.26 -4.51 -6.55
Interest Expense
-0.07 0.47 0.48 0.65 1.25 1.22 0.97 1.83 3.81 4.42 5.36
Other Income / (Expense), net
-0.65 3.44 -0.15 0.65 -1.30 0.04 -0.49 1.89 -1.45 -0.09 -1.19
Income Tax Expense
5.49 7.66 7.46 6.46 6.05 9.12 13 15 14 20 22
Basic Earnings per Share
$0.84 $1.50 $0.91 - $2.63 $3.14 $5.59 $6.02 $5.48 $6.82 $8.23
Weighted Average Basic Shares Outstanding
9.01M 8.50M 8.29M 8.11M 7.87M 7.77M 7.42M 7.22M 7.01M 6.82M 6.64M
Diluted Earnings per Share
$0.83 $1.49 $0.89 - $2.53 $3.07 $5.45 $5.91 $5.39 $6.74 $8.14
Weighted Average Diluted Shares Outstanding
9.20M 8.60M 8.50M 8.57M 8.17M 7.95M 7.62M 7.36M 7.12M 6.91M 6.71M
Weighted Average Basic & Diluted Shares Outstanding
8.93M 8.54M 8.38M 8.05M 7.85M 7.65M 7.40M 7.18M 6.96M 6.79M 6.57M
Cash Dividends to Common per Share
- $0.14 $0.59 $0.71 $0.83 $0.95 $1.09 $1.29 $1.50 $1.75 $2.04

Quarterly Income Statements for Charles River Associates

This table shows Charles River Associates' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2026 Q2 2026 Q3 2026
Period end date 4/1/2023 7/1/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 4/4/2026 6/28/2025 9/27/2025
Net Income / (Loss) Attributable to Common Shareholders
8.92 9.51 8.60 11 14 6.54 11 15 11 12 11
Consolidated Net Income / (Loss)
8.92 9.51 8.60 11 14 6.54 11 15 11 12 11
Net Income / (Loss) Continuing Operations
8.92 9.51 8.60 11 14 6.54 11 15 11 12 11
Total Pre-Tax Income
13 14 11 16 19 9.61 16 22 17 17 16
Total Operating Income
14 16 11 17 20 11 18 21 18 20 17
Total Gross Profit
45 49 42 49 53 46 53 56 56 58 54
Total Revenue
153 162 148 162 172 171 168 176 201 187 186
Operating Revenue
153 162 148 162 172 171 168 176 201 187 186
Total Cost of Revenue
108 113 106 113 119 125 115 121 145 129 131
Operating Cost of Revenue
108 113 106 113 119 125 115 121 145 129 131
Total Operating Expenses
31 33 31 32 33 35 34 34 38 39 37
Selling, General & Admin Expense
28 30 28 29 30 32 31 31 35 35 34
Depreciation Expense
2.94 2.87 2.95 2.80 2.79 2.81 2.90 3.17 3.39 3.53 3.49
Total Other Income / (Expense), net
-1.10 -2.30 -0.27 -1.59 -0.61 -1.67 -2.36 0.13 -0.63 -2.61 -0.99
Interest Expense
0.57 1.62 1.03 0.60 0.46 1.48 1.46 1.01 1.01 1.80 1.75
Other Income / (Expense), net
-0.53 -0.69 0.76 -0.99 -0.14 -0.19 -0.90 1.15 0.38 -0.82 0.76
Income Tax Expense
3.68 4.10 1.93 4.10 5.32 3.08 4.59 6.60 6.27 4.99 4.75
Basic Earnings per Share
$1.25 $1.36 $1.22 $1.65 $1.97 $0.96 $1.68 $2.21 $1.71 $1.81 $1.74
Weighted Average Basic Shares Outstanding
7.12M 6.98M 6.98M 7.01M 6.93M 6.83M 6.76M 6.82M 6.51M 6.69M 6.56M
Diluted Earnings per Share
$1.23 $1.34 $1.21 $1.61 $1.95 $0.94 $1.67 $2.18 $1.69 $1.79 $1.73
Weighted Average Diluted Shares Outstanding
7.25M 7.08M 7.08M 7.12M 7.01M 6.91M 6.84M 6.91M 6.59M 6.75M 6.62M
Weighted Average Basic & Diluted Shares Outstanding
7.03M 7.00M 7.00M 6.96M 6.92M 6.78M 6.78M 6.79M 6.46M 6.58M 6.56M
Cash Dividends to Common per Share
- $0.36 $0.36 - $0.42 - $0.42 - - - $0.49

Annual Cash Flow Statements for Charles River Associates

This table details how cash moves in and out of Charles River Associates' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Net Change in Cash & Equivalents
-10 15 0.51 -15 -12 20 20 -35 14 -19 -8.50
Net Cash From Operating Activities
20 48 46 36 28 55 76 25 60 50 22
Net Cash From Continuing Operating Activities
20 48 46 36 28 59 76 25 60 50 22
Net Income / (Loss) Continuing Operations
6.33 14 7.70 22 21 25 42 44 38 47 55
Consolidated Net Income / (Loss)
6.33 14 7.70 22 21 25 42 44 38 47 55
Depreciation Expense
6.54 7.88 8.86 10.00 11 13 13 12 12 12 14
Amortization Expense
- - - 0.00 11 12 13 14 14 15 15
Non-Cash Adjustments To Reconcile Net Income
16 17 9.88 -12 -13 0.88 10 -11 2.60 -7.21 -54
Changes in Operating Assets and Liabilities, net
-8.56 9.40 19 16 -1.05 8.91 -1.91 -33 -6.85 -17 -8.26
Net Cash From Investing Activities
-16 -12 -26 -15 -17 -17 -2.62 -18 -2.94 -18 -3.87
Net Cash From Continuing Investing Activities
-16 -12 -26 -15 -17 -17 -2.62 -18 -2.94 -18 -3.87
Purchase of Property, Plant & Equipment
-18 -13 -9.76 -15 -17 -17 -2.62 -3.81 -2.37 -17 -3.87
Acquisitions
- 0.00 -16 - - 0.00 0.00 -14 -0.58 -1.50 0.00
Net Cash From Financing Activities
-13 -19 -22 -36 -24 -20 -52 -39 -44 -49 -30
Net Cash From Continuing Financing Activities
-13 -19 -22 -36 -24 -20 -52 -39 -44 -49 -30
Repayment of Debt
-4.30 -7.58 -12 -30 -54 -77 -74 -127 -105 -102 -98
Repurchase of Common Equity
-13 -19 -20 -28 -18 -13 -45 -28 -31 -33 -47
Payment of Dividends
- -1.17 -5.48 -6.08 -6.79 -7.50 -8.29 -9.58 -11 -12 -14
Issuance of Debt
4.00 7.50 12 30 54 77 74 126 105 102 132
Issuance of Common Equity
0.60 2.85 6.42 2.17 3.21 2.24 5.16 1.41 0.81 0.00 0.00
Other Financing Activities, net
-0.54 -1.49 -3.26 -3.95 -2.18 -0.86 -3.89 -2.15 -3.06 -3.21 -2.86
Effect of Exchange Rate Changes
-0.94 -1.66 2.17 - 0.29 1.97 -0.63 -2.69 1.49 -1.63 2.79
Cash Interest Paid
0.24 0.41 0.31 0.51 1.16 1.16 0.73 1.58 3.54 4.15 4.66
Cash Income Taxes Paid
9.69 6.18 7.42 4.81 7.59 6.54 15 16 1.17 2.05 0.00

Quarterly Cash Flow Statements for Charles River Associates

This table details how cash moves in and out of Charles River Associates' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2026 Q2 2026 Q3 2026
Period end date 4/1/2023 7/1/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025
Net Change in Cash & Equivalents
4.07 -21 13 18 -8.46 -12 -0.17 2.23 -1.11 -6.15 3.05
Net Cash From Operating Activities
-70 5.07 65 60 -63 1.81 32 79 -80 5.85 37
Net Cash From Continuing Operating Activities
-70 5.07 65 60 -63 1.81 32 79 -80 6.45 37
Net Income / (Loss) Continuing Operations
8.92 9.51 8.60 11 14 6.54 11 15 18 12 11
Consolidated Net Income / (Loss)
8.92 9.51 8.60 11 14 6.54 11 15 18 12 11
Depreciation Expense
2.94 2.87 2.95 2.80 2.79 2.81 2.90 3.17 3.41 3.53 3.49
Amortization Expense
3.57 3.62 3.41 3.67 3.57 3.90 3.85 3.84 3.85 3.90 3.90
Non-Cash Adjustments To Reconcile Net Income
-32 0.59 2.63 32 -16 -16 -13 38 -48 -5.36 -39
Changes in Operating Assets and Liabilities, net
-53 -12 47 10 -67 4.83 26 19 -57 -7.74 57
Net Cash From Investing Activities
-1.13 -0.72 -0.73 -0.36 -0.73 -3.82 -2.99 -11 -0.97 -1.19 -0.65
Net Cash From Continuing Investing Activities
-1.13 -0.72 -0.73 -0.36 -0.73 -3.82 -2.99 -11 -0.97 -1.19 -0.65
Purchase of Property, Plant & Equipment
-0.56 -0.72 -0.73 -0.36 -0.73 -2.32 -2.99 -11 -0.97 -1.19 -0.65
Net Cash From Financing Activities
75 -26 -51 -43 56 -10 -30 -65 79 -12 -32
Net Cash From Continuing Financing Activities
75 -26 -51 -43 56 -10 -30 -65 79 -12 -32
Repayment of Debt
-5.00 -20 -48 -32 0.00 -6.00 -29 -67 -5.00 -7.00 -25
Repurchase of Common Equity
-21 -3.00 - -7.84 -9.24 -24 - - 0.00 -43 -4.00
Payment of Dividends
-2.70 -2.53 -2.54 -3.03 -3.08 -2.90 -2.87 -3.45 -3.49 -3.37 -3.24
Other Financing Activities, net
-1.87 -0.14 -0.03 -1.02 -1.63 -0.35 -0.05 -1.18 -2.45 -0.36 -0.05
Effect of Exchange Rate Changes
0.41 0.06 -0.31 1.33 -0.71 -0.11 1.16 -1.97 0.80 1.06 -0.56
Cash Interest Paid
0.12 2.05 0.73 0.64 0.09 1.44 1.55 1.06 0.13 1.54 1.92
Cash Income Taxes Paid
1.08 5.14 3.74 4.06 1.53 11 4.40 4.36 3.18 12 5.51

Annual Balance Sheets for Charles River Associates

This table presents Charles River Associates' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Total Assets
314 324 362 371 533 559 555 551 553 571 629
Total Current Assets
141 171 184 181 184 220 249 249 265 269 303
Cash & Equivalents
38 54 54 38 26 46 66 31 46 27 18
Note & Lease Receivable
4.40 5.90 5.54 6.10 6.75 15 11 9.67 8.76 6.54 17
Accounts Receivable
86 92 113 131 144 152 162 195 200 220 249
Prepaid Expenses
12 19 11 6.42 7.28 7.07 11 13 12 17 19
Plant, Property, & Equipment, net
31 36 45 48 61 63 54 46 38 45 37
Total Noncurrent Assets
142 117 133 142 288 276 252 256 250 257 289
Goodwill
77 75 89 88 89 89 89 93 94 94 95
Intangible Assets
3.59 2.69 9.21 7.85 6.48 5.11 4.18 8.59 7.20 7.22 5.69
Noncurrent Deferred & Refundable Income Taxes
19 10 8.71 9.33 11 9.67 9.32 9.16 14 17 18
Other Noncurrent Operating Assets
42 29 26 36 182 172 150 146 134 139 171
Total Liabilities & Shareholders' Equity
314 324 362 371 533 559 555 551 553 571 629
Total Liabilities
103 116 155 174 335 349 350 340 341 359 415
Total Current Liabilities
86 94 122 142 171 200 213 217 236 251 330
Short-Term Debt
0.08 - 0.00 - - - - - - 0.00 34
Accounts Payable
14 14 18 22 26 19 24 28 29 28 30
Accrued Expenses
65 75 95 108 121 136 156 156 171 181 223
Current Deferred Revenue
6.80 4.52 8.03 8.68 6.72 9.87 13 12 12 14 14
Current Employee Benefit Liabilities
0.81 0.57 0.91 3.65 4.47 21 6.10 5.69 7.58 8.92 11
Other Current Liabilities
- - - - 13 14 14 16 16 19 17
Total Noncurrent Liabilities
16 22 33 32 164 149 136 123 105 108 85
Noncurrent Deferred & Payable Income Tax Liabilities
- 0.12 0.37 0.30 0.50 0.73 1.03 0.95 1.06 1.19 0.73
Noncurrent Employee Benefit Liabilities
4.36 6.35 12 7.96 15 9.19 11 16 12 22 8.51
Other Noncurrent Operating Liabilities
- - - - 147 139 124 106 92 85 76
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
211 208 207 196 198 209 206 211 212 212 214
Total Preferred & Common Equity
212 207 207 196 198 209 206 211 212 212 214
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
212 207 207 196 198 209 206 211 212 212 214
Common Stock
66 54 47 23 9.27 0.50 0.00 1.74 0.00 1.66 2.48
Retained Earnings
155 167 169 186 200 217 216 224 224 225 221
Accumulated Other Comprehensive Income / (Loss)
-9.25 -14 -9.90 -13 -12 -8.48 -9.95 -15 -12 -15 -9.94

Quarterly Balance Sheets for Charles River Associates

This table presents Charles River Associates' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2022 Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2026 Q2 2026 Q3 2026
Period end date 7/2/2022 10/1/2022 4/1/2023 7/1/2023 9/30/2023 3/30/2024 6/29/2024 9/28/2024 4/4/2026 6/28/2025 9/27/2025
Total Assets
547 554 562 551 539 553 546 582 662 607 629
Total Current Assets
241 257 258 255 249 275 271 286 316 293 306
Cash & Equivalents
16 24 36 14 28 37 25 24 32 19 22
Note & Lease Receivable
12 10 14 12 10 15 14 10 26 18 21
Accounts Receivable
200 209 197 213 193 209 217 233 233 235 243
Prepaid Expenses
13 14 12 15 17 14 16 18 25 21 19
Plant, Property, & Equipment, net
49 47 44 42 40 37 37 38 36 41 39
Total Noncurrent Assets
257 250 260 254 250 240 238 258 310 272 284
Goodwill
90 89 94 94 93 94 94 95 94 95 95
Intangible Assets
7.78 7.47 8.23 7.89 7.54 6.85 7.98 7.60 5.30 6.45 6.07
Noncurrent Deferred & Refundable Income Taxes
9.47 9.45 9.40 9.40 10 14 14 13 17 17 18
Other Noncurrent Operating Assets
150 144 149 143 139 126 122 143 193 154 166
Total Liabilities & Shareholders' Equity
547 554 562 551 539 553 546 582 662 607 629
Total Liabilities
349 354 365 348 331 341 354 378 464 410 427
Total Current Liabilities
222 231 254 239 224 237 253 268 381 317 339
Short-Term Debt
70 45 100 80 32 70 87 60 192 120 95
Accounts Payable
25 26 23 23 25 33 23 28 24 25 26
Accrued Expenses
102 133 104 107 138 106 113 146 132 140 183
Current Deferred Revenue
6.85 7.33 8.91 9.00 7.87 9.08 8.48 8.45 13 9.04 8.03
Current Employee Benefit Liabilities
2.67 4.20 1.44 3.52 5.55 1.59 3.98 6.47 2.23 5.19 7.84
Other Current Liabilities
15 15 16 16 16 17 17 19 17 19 19
Total Noncurrent Liabilities
127 123 112 109 107 104 102 110 83 92 89
Noncurrent Deferred & Payable Income Tax Liabilities
0.92 0.85 0.98 1.00 0.97 1.05 1.05 1.12 0.71 1.30 1.27
Noncurrent Employee Benefit Liabilities
11 13 8.60 10 10 14 16 19 12 5.99 6.85
Other Noncurrent Operating Liabilities
115 109 102 98 95 89 84 89 71 85 81
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
198 201 197 203 208 212 192 205 198 197 202
Total Preferred & Common Equity
198 201 197 203 208 212 192 205 198 197 202
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
198 201 197 203 208 212 192 205 198 197 202
Common Stock
0.00 1.03 0.00 0.47 1.36 0.00 0.00 1.31 0.00 0.00 0.54
Retained Earnings
213 218 211 215 221 225 205 214 209 206 212
Accumulated Other Comprehensive Income / (Loss)
-15 -19 -14 -13 -15 -13 -14 -11 -11 -9.49 -11

Annual Metrics And Ratios for Charles River Associates

This table displays calculated financial ratios and metrics derived from Charles River Associates' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
DEI Shares Outstanding
- - - - - - - - - - 6,562,262.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 6,562,262.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 8.35
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-0.92% 6.99% 13.95% 12.86% 8.07% 12.63% 11.32% 4.41% 5.60% 10.17% 9.33%
EBITDA Growth
-39.41% 65.31% -19.05% 61.71% 24.72% 20.98% 35.68% 6.61% -5.14% 18.97% 14.32%
EBIT Growth
-50.53% 90.33% -30.16% 89.45% -5.17% 24.20% 58.58% 9.74% -7.47% 25.95% 15.95%
NOPAT Growth
-52.01% 85.41% -34.92% 180.72% 1.11% 11.62% 68.76% 1.80% -2.81% 17.66% 19.35%
Net Income Growth
-52.82% 125.03% -45.89% 191.81% -7.68% 18.12% 70.07% 4.65% -11.78% 21.24% 17.42%
EPS Growth
-39.86% 79.52% -40.27% 0.00% 0.00% 21.34% 77.52% 8.44% -8.80% 25.05% 20.77%
Operating Cash Flow Growth
-32.26% 135.82% -4.79% -21.08% -23.09% 96.40% 38.48% -66.81% 139.13% -17.21% -54.91%
Free Cash Flow Firm Growth
-94.61% 2,671.17% -70.39% 87.93% -47.43% 276.99% 94.66% -94.63% 1,456.11% -44.22% -50.16%
Invested Capital Growth
3.29% -10.78% -0.75% 3.43% 8.63% -5.10% -14.47% 28.63% -7.34% 11.32% 23.75%
Revenue Q/Q Growth
-1.94% 2.24% 4.95% 2.89% 2.38% 3.70% -0.47% 1.76% 2.74% 2.20% 0.00%
EBITDA Q/Q Growth
-31.61% 25.66% -14.35% 32.45% 2.12% 6.85% 3.27% -0.55% 5.92% 7.71% 0.00%
EBIT Q/Q Growth
-42.05% 35.90% -21.58% 45.33% -6.84% 9.16% 5.42% -0.82% 8.79% 10.03% 0.00%
NOPAT Q/Q Growth
-48.68% 57.95% -35.44% 61.95% -3.26% 8.41% 3.14% 3.02% 5.76% 4.72% 0.00%
Net Income Q/Q Growth
-50.03% 48.76% -36.03% 68.05% -9.10% 8.61% 4.94% 0.01% 7.81% 8.18% 0.00%
EPS Q/Q Growth
-38.97% 35.45% -36.43% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 9.24% 0.00%
Operating Cash Flow Q/Q Growth
40.53% 16.05% 15.39% 21.96% 12.79% 47.39% -4.44% -6.19% -0.06% 63.55% 0.00%
Free Cash Flow Firm Q/Q Growth
181.09% 48.35% 27.99% 130.42% 4.68% 150.48% -3.94% -68.50% 12.73% 55.63% 0.00%
Invested Capital Q/Q Growth
-11.33% -15.21% -18.20% -18.19% -17.46% -25.17% -26.71% -18.90% -21.59% -22.78% 0.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
31.59% 29.99% 30.06% 30.76% 29.60% 27.08% 29.31% 30.60% 29.52% 30.18% 100.00%
EBITDA Margin
6.02% 9.31% 6.61% 9.48% 10.94% 11.75% 14.32% 14.62% 13.13% 14.18% 14.83%
Operating Margin
4.08% 5.83% 4.26% 6.93% 6.50% 6.84% 9.85% 9.94% 9.22% 10.29% 11.06%
EBIT Margin
3.87% 6.88% 4.22% 7.08% 6.21% 6.85% 9.76% 10.26% 8.99% 10.28% 10.90%
Profit (Net Income) Margin
2.08% 4.38% 2.08% 5.38% 4.60% 4.82% 7.36% 7.38% 6.17% 6.79% 7.29%
Tax Burden Percent
53.53% 65.02% 50.78% 77.67% 77.42% 72.89% 76.79% 74.18% 73.59% 70.43% 71.54%
Interest Burden Percent
100.58% 97.90% 97.12% 97.81% 95.53% 96.51% 98.24% 96.99% 93.21% 93.75% 93.46%
Effective Tax Rate
46.47% 34.98% 49.22% 22.33% 22.58% 27.11% 23.21% 25.82% 26.41% 29.57% 28.46%
Return on Invested Capital (ROIC)
3.90% 7.52% 5.21% 14.42% 13.75% 15.12% 28.25% 27.28% 24.46% 28.32% 28.68%
ROIC Less NNEP Spread (ROIC-NNEP)
4.62% 3.30% 5.77% 14.43% 19.95% 17.52% 30.26% 27.19% 34.51% 37.11% 114.51%
Return on Net Nonoperating Assets (RNNOA)
-0.93% -0.72% -1.50% -3.29% -3.22% -3.07% -8.16% -6.36% -6.28% -6.32% -2.94%
Return on Equity (ROE)
2.97% 6.79% 3.71% 11.13% 10.53% 12.05% 20.09% 20.92% 18.18% 22.00% 25.74%
Cash Return on Invested Capital (CROIC)
0.66% 18.91% 5.96% 11.05% 5.48% 20.35% 43.85% 2.23% 32.08% 17.61% 7.45%
Operating Return on Assets (OROA)
3.75% 7.02% 4.56% 8.08% 6.21% 6.38% 9.92% 10.96% 10.16% 12.57% 13.65%
Return on Assets (ROA)
2.02% 4.47% 2.25% 6.13% 4.59% 4.49% 7.48% 7.89% 6.97% 8.30% 9.13%
Return on Common Equity (ROCE)
2.97% 6.80% 3.70% 11.12% 10.53% 12.05% 20.09% 20.92% 18.18% 22.00% 25.74%
Return on Equity Simple (ROE_SIMPLE)
2.99% 6.87% 3.72% 11.44% 10.49% 11.72% 20.25% 20.66% 18.14% 22.00% 0.00%
Net Operating Profit after Tax (NOPAT)
6.63 12 8.01 22 23 25 43 44 42 50 59
NOPAT Margin
2.19% 3.79% 2.16% 5.38% 5.03% 4.99% 7.56% 7.37% 6.79% 7.25% 7.91%
Net Nonoperating Expense Percent (NNEP)
-0.73% 4.22% -0.57% 0.00% -6.20% -2.40% -2.01% 0.10% -10.04% -8.78% -85.83%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 20.64% 19.97% 23.50% 24.02%
Cost of Revenue to Revenue
68.41% 70.01% 69.94% 69.24% 70.40% 72.92% 70.69% 69.40% 70.48% 69.82% 0.00%
SG&A Expenses to Revenue
23.86% 21.73% 23.38% 21.44% 20.74% 17.71% 17.21% 18.63% 18.45% 18.19% 17.97%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
27.51% 24.16% 25.80% 23.83% 23.10% 20.23% 19.46% 20.66% 20.30% 19.89% 88.94%
Earnings before Interest and Taxes (EBIT)
12 22 16 30 28 35 55 61 56 71 82
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
18 30 24 40 49 60 81 86 82 97 111
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.70 1.30 1.59 1.55 1.96 1.81 3.26 4.03 3.23 5.97 6.16
Price to Tangible Book Value (P/TBV)
1.13 2.08 3.03 3.03 3.77 3.30 5.95 7.77 6.17 11.40 11.62
Price to Revenue (P/Rev)
0.49 0.83 0.89 0.73 0.86 0.74 1.18 1.44 1.10 1.84 1.75
Price to Earnings (P/E)
19.37 20.93 43.25 13.52 18.67 15.42 16.08 19.53 17.80 27.15 24.02
Dividend Yield
0.00% 0.43% 1.45% 1.89% 1.66% 1.95% 1.21% 1.08% 1.53% 0.94% 1.02%
Earnings Yield
5.16% 4.78% 2.31% 7.40% 5.36% 6.48% 6.22% 5.12% 5.62% 3.68% 4.16%
Enterprise Value to Invested Capital (EV/IC)
0.63 1.40 1.80 1.68 2.10 2.03 4.32 4.56 3.84 6.69 5.81
Enterprise Value to Revenue (EV/Rev)
0.36 0.67 0.75 0.64 0.80 0.65 1.07 1.39 1.02 1.80 1.77
Enterprise Value to EBITDA (EV/EBITDA)
5.99 7.17 11.28 6.72 7.33 5.57 7.46 9.50 7.80 12.72 11.95
Enterprise Value to EBIT (EV/EBIT)
9.32 9.70 17.68 8.99 12.89 9.54 10.94 13.53 11.40 17.55 16.25
Enterprise Value to NOPAT (EV/NOPAT)
16.51 17.62 34.48 11.83 15.92 13.10 14.12 18.83 15.10 24.89 22.39
Enterprise Value to Operating Cash Flow (EV/OCF)
5.36 4.50 6.02 7.35 13.00 6.08 7.98 32.65 10.64 24.93 59.39
Enterprise Value to Free Cash Flow (EV/FCFF)
98.06 7.00 30.12 15.44 39.95 9.74 9.09 229.83 11.51 40.02 86.23
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.16
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.20 -0.22 -0.26 -0.23 -0.16 -0.18 -0.27 -0.23 -0.18 -0.17 -0.03
Leverage Ratio
1.47 1.52 1.65 1.81 2.29 2.68 2.69 2.65 2.61 2.65 2.82
Compound Leverage Factor
1.48 1.49 1.60 1.78 2.19 2.59 2.64 2.57 2.43 2.49 2.64
Debt to Total Capital
0.04% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 13.73%
Short-Term Debt to Total Capital
0.04% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 13.73%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
-0.33% 0.32% 0.15% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.29% 99.68% 99.85% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 86.27%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.31
Net Debt to EBITDA
-2.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.14
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.57
Net Debt to NOPAT
-5.74 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.27
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
2.86 3.63 3.31 3.26 2.27 2.35 3.12 3.58 3.30 4.32 3.97
Noncontrolling Interest Sharing Ratio
-0.02% -0.01% 0.24% 0.08% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.63 1.81 1.51 1.27 1.07 1.10 1.17 1.15 1.12 1.07 0.92
Quick Ratio
1.49 1.61 1.42 1.23 1.03 1.06 1.12 1.09 1.08 1.01 0.86
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1.12 31 9.16 17 9.05 34 66 3.57 56 31 15
Operating Cash Flow to CapEx
124.40% 369.83% 470.00% 234.28% 166.73% 319.78% 2,885.93% 658.83% 2,538.97% 299.19% 579.73%
Free Cash Flow to Firm to Interest Expense
0.00 66.00 18.94 26.62 7.22 28.07 68.50 1.95 14.57 7.01 2.88
Operating Cash Flow to Interest Expense
0.00 102.69 94.75 55.93 22.19 44.95 78.04 13.76 15.76 11.26 4.19
Operating Cash Flow Less CapEx to Interest Expense
0.00 74.93 74.59 32.06 8.88 30.90 75.34 11.67 15.14 7.50 3.46
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.97 1.02 1.08 1.14 1.00 0.93 1.02 1.07 1.13 1.22 1.25
Accounts Receivable Turnover
3.58 3.65 3.61 3.42 3.28 3.42 3.60 3.31 3.16 3.28 3.21
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
13.19 9.59 9.13 9.01 8.25 8.19 9.72 11.91 14.90 16.49 18.35
Accounts Payable Turnover
15.18 16.61 16.08 14.31 13.24 16.30 18.63 16.05 15.63 16.88 0.00
Days Sales Outstanding (DSO)
101.93 100.12 101.15 106.59 111.19 106.58 101.43 110.27 115.40 111.27 113.74
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
24.04 21.98 22.71 25.50 27.57 22.40 19.59 22.74 23.36 21.62 0.00
Cash Conversion Cycle (CCC)
77.89 78.14 78.45 81.08 83.62 84.18 81.84 87.53 92.04 89.65 113.74
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
173 154 153 158 172 163 140 180 167 185 229
Invested Capital Turnover
1.78 1.98 2.41 2.68 2.73 3.03 3.74 3.70 3.60 3.91 3.62
Increase / (Decrease) in Invested Capital
5.52 -19 -1.16 5.25 14 -8.77 -24 40 -13 19 44
Enterprise Value (EV)
110 217 276 266 362 332 604 820 639 1,240 1,332
Market Capitalization
148 270 330 304 387 378 670 852 685 1,267 1,316
Book Value per Share
$23.61 $25.05 $25.52 $24.25 $25.55 $26.88 $27.71 $29.59 $30.29 $31.28 $32.55
Tangible Book Value per Share
$14.63 $15.68 $13.40 $12.40 $13.28 $14.75 $15.18 $15.37 $15.84 $16.39 $17.25
Total Capital
211 208 207 196 198 209 206 211 212 212 248
Total Debt
0.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 34
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-38 -54 -54 -38 -26 -46 -66 -31 -46 -27 16
Capital Expenditures (CapEx)
16 13 9.76 15 17 17 2.62 3.81 2.37 17 3.87
Debt-free, Cash-free Net Working Capital (DFCFNWC)
16 23 8.27 0.62 -13 -26 -30 0.29 -16 -8.66 -11
Debt-free Net Working Capital (DFNWC)
54 76 62 39 13 20 36 32 29 18 7.10
Net Working Capital (NWC)
54 76 62 39 13 20 36 32 29 18 -27
Net Nonoperating Expense (NNE)
0.31 -1.93 0.30 0.00 1.98 0.86 1.12 -0.05 3.87 3.18 4.69
Net Nonoperating Obligations (NNO)
-38 -54 -54 -38 -26 -46 -66 -31 -46 -27 16
Total Depreciation and Amortization (D&A)
6.54 7.88 8.86 10.00 21 25 26 26 26 27 30
Debt-free, Cash-free Net Working Capital to Revenue
5.36% 7.05% 2.23% 0.15% -2.87% -5.08% -5.28% 0.05% -2.60% -1.26% -1.48%
Debt-free Net Working Capital to Revenue
17.92% 23.53% 16.83% 9.25% 2.81% 3.90% 6.41% 5.37% 4.71% 2.63% 0.94%
Net Working Capital to Revenue
17.90% 23.53% 16.83% 9.25% 2.81% 3.90% 6.41% 5.37% 4.71% 2.63% -3.58%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $1.50 $0.91 $2.76 $2.63 $0.00 $5.59 $6.02 $5.48 $6.82 $8.23
Adjusted Weighted Average Basic Shares Outstanding
9.01M 8.50M 8.29M 8.11M 7.87M 7.77M 7.42M 7.22M 7.01M 6.82M 6.64M
Adjusted Diluted Earnings per Share
$0.00 $1.49 $0.89 $2.61 $2.53 $0.00 $5.45 $5.91 $5.39 $6.74 $8.14
Adjusted Weighted Average Diluted Shares Outstanding
9.20M 8.60M 8.50M 8.57M 8.17M 7.95M 7.62M 7.36M 7.12M 6.91M 6.71M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
8.93M 8.54M 8.38M 8.05M 7.85M 7.65M 7.40M 7.18M 6.96M 6.79M 6.57M
Normalized Net Operating Profit after Tax (NOPAT)
9.06 12 8.01 22 23 25 43 44 42 50 59
Normalized NOPAT Margin
2.98% 3.79% 2.16% 5.38% 5.03% 4.99% 7.56% 7.37% 6.79% 7.25% 7.91%
Pre Tax Income Margin
3.89% 6.74% 4.10% 6.93% 5.94% 6.61% 9.59% 9.95% 8.38% 9.64% 10.19%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 47.67 32.26 45.72 22.37 28.65 56.95 33.20 14.72 16.00 15.29
NOPAT to Interest Expense
0.00 26.23 16.54 34.74 18.12 20.86 44.13 23.86 11.11 11.28 11.10
EBIT Less CapEx to Interest Expense
0.00 19.90 12.10 21.84 9.06 14.59 54.25 31.11 14.10 12.23 14.57
NOPAT Less CapEx to Interest Expense
0.00 -1.54 -3.62 10.86 4.81 6.80 41.42 21.77 10.49 7.52 10.38
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 8.19% 71.17% 27.07% 32.70% 30.62% 19.89% 21.96% 28.08% 26.36% 25.25%
Augmented Payout Ratio
202.47% 143.90% 324.75% 151.15% 119.79% 85.18% 127.80% 85.31% 109.73% 97.85% 111.31%

Quarterly Metrics And Ratios for Charles River Associates

This table displays calculated financial ratios and metrics derived from Charles River Associates' official financial filings.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2026 Q2 2026 Q3 2026
Period end date 4/1/2023 7/1/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
3.01% 8.63% -0.60% 11.48% 12.39% 5.85% 13.69% 9.17% 0.00% 0.00% 0.00%
EBITDA Growth
-10.89% -6.41% -22.26% 25.35% 31.28% -18.04% 35.36% 30.84% 0.00% 0.00% 0.00%
EBIT Growth
-16.30% -8.89% -30.27% 39.01% 47.94% -27.13% 51.43% 39.85% 0.00% 0.00% 0.00%
NOPAT Growth
-15.19% 3.31% -20.78% 21.95% 45.70% -30.94% 48.83% 17.96% 0.00% 0.00% 0.00%
Net Income Growth
-21.95% -18.34% -27.62% 32.12% 53.52% -31.24% 33.05% 30.79% 0.00% 0.00% 0.00%
EPS Growth
0.00% 0.00% -25.77% 0.00% 58.54% -29.85% 38.02% 35.40% 0.00% 0.00% 0.00%
Operating Cash Flow Growth
-13.28% 129.88% 48.30% -0.06% 9.95% -64.37% -51.37% 32.16% 0.00% 0.00% 0.00%
Free Cash Flow Firm Growth
-564.39% 60.52% 190.99% 187.08% 217.96% 538.84% -180.67% -115.31% 0.00% 0.00% 0.00%
Invested Capital Growth
15.85% 6.40% -4.16% -7.34% -6.35% -5.37% 13.03% 11.32% 0.00% 0.00% 0.00%
Revenue Q/Q Growth
5.43% 5.97% -8.90% 9.53% 6.30% -0.20% -2.15% 5.18% 0.00% 2.76% -0.53%
EBITDA Q/Q Growth
8.99% 10.39% -17.58% 26.41% 14.14% -31.08% 36.11% 22.19% 0.00% -18.55% -3.73%
EBIT Q/Q Growth
13.26% 15.67% -24.17% 39.93% 20.53% -43.02% 57.58% 29.23% 0.00% -24.58% -4.96%
NOPAT Q/Q Growth
-6.36% 14.64% -20.69% 43.22% 11.88% -45.66% 70.93% 13.52% 0.00% -25.13% -12.89%
Net Income Q/Q Growth
2.82% 6.62% -9.59% 33.31% 19.48% -52.25% 74.93% 31.04% 0.00% -32.66% -5.35%
EPS Q/Q Growth
0.00% 8.94% -9.70% 33.06% 21.12% -51.79% 77.66% 30.54% 0.00% -31.68% -3.35%
Operating Cash Flow Q/Q Growth
-216.49% 107.24% 1,180.60% -7.47% -204.96% 102.86% 1,647.87% 151.47% 0.00% 107.32% 524.52%
Free Cash Flow Firm Q/Q Growth
12.15% 80.67% 458.45% 43.09% 19.00% -28.10% -165.89% 72.85% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
45.38% 2.78% -20.92% -21.59% 46.93% 3.86% -5.54% -22.78% 0.00% 3.78% -7.86%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
29.45% 30.03% 28.23% 30.27% 30.80% 26.90% 31.33% 31.68% 33.82% 31.22% 29.28%
EBITDA Margin
12.87% 13.41% 12.13% 14.00% 15.04% 10.39% 14.45% 16.78% 17.78% 14.09% 13.64%
Operating Margin
8.96% 9.83% 7.31% 10.61% 11.42% 6.58% 10.96% 12.16% 14.05% 10.56% 9.26%
EBIT Margin
8.61% 9.40% 7.83% 10.00% 11.34% 6.47% 10.42% 12.81% 13.79% 10.12% 9.67%
Profit (Net Income) Margin
5.83% 5.87% 5.83% 7.09% 7.97% 3.81% 6.82% 8.49% 9.90% 6.49% 6.17%
Tax Burden Percent
70.81% 69.85% 81.69% 73.65% 72.01% 68.01% 71.35% 69.43% 73.05% 70.82% 70.72%
Interest Burden Percent
95.66% 89.39% 91.12% 96.29% 97.62% 86.64% 91.67% 95.52% 98.29% 90.50% 90.26%
Effective Tax Rate
29.19% 30.15% 18.31% 26.35% 27.99% 32.00% 28.65% 30.57% 26.95% 29.18% 29.28%
Return on Invested Capital (ROIC)
15.52% 16.03% 16.73% 28.16% 20.90% 11.18% 23.26% 32.99% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
13.59% 13.35% 14.98% 31.20% 20.00% 9.40% 14.82% 32.73% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
2.70% 4.00% 0.93% -5.68% 4.77% 3.05% 1.43% -5.58% 0.00% 0.00% 0.00%
Return on Equity (ROE)
18.22% 20.03% 17.65% 22.48% 25.67% 14.23% 24.69% 27.41% 0.00% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)
2.52% 10.05% 22.71% 32.08% 25.05% 22.10% 8.80% 17.61% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
9.22% 10.42% 8.70% 11.30% 13.08% 7.70% 12.51% 15.66% 0.00% 0.00% 0.00%
Return on Assets (ROA)
6.24% 6.50% 6.47% 8.01% 9.19% 4.54% 8.18% 10.38% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)
18.22% 20.03% 17.65% 22.48% 25.67% 14.23% 24.69% 27.41% 0.00% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)
20.89% 19.22% 17.16% 0.00% 20.42% 21.01% 21.09% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
9.70 11 8.82 13 14 7.68 13 15 19 14 12
NOPAT Margin
6.34% 6.86% 5.98% 7.81% 8.22% 4.48% 7.82% 8.44% 10.26% 7.48% 6.55%
Net Nonoperating Expense Percent (NNEP)
1.93% 2.68% 1.74% -3.03% 0.90% 1.78% 8.44% 0.25% 1.11% 1.84% 0.96%
Return On Investment Capital (ROIC_SIMPLE)
- - - 5.95% 5.01% - - 7.02% 5.98% 4.41% 4.10%
Cost of Revenue to Revenue
70.55% 69.97% 71.77% 69.73% 69.20% 73.10% 68.67% 68.32% 66.18% 68.78% 70.72%
SG&A Expenses to Revenue
18.56% 18.43% 18.92% 17.93% 17.75% 18.67% 18.64% 17.72% 17.89% 18.77% 18.14%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
20.49% 20.20% 20.92% 19.66% 19.38% 20.31% 20.37% 19.52% 19.77% 20.66% 20.02%
Earnings before Interest and Taxes (EBIT)
13 15 12 16 19 11 17 23 25 19 18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
20 22 18 23 26 18 24 30 32 26 25
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.87 3.49 3.35 3.23 4.87 6.21 5.57 5.97 5.18 6.46 6.70
Price to Tangible Book Value (P/TBV)
8.02 7.00 6.52 6.17 9.28 13.25 11.12 11.40 9.32 13.32 13.38
Price to Revenue (P/Rev)
1.28 1.16 1.15 1.10 1.60 1.83 1.69 1.84 0.00 0.00 0.00
Price to Earnings (P/E)
18.52 18.15 19.52 17.80 23.84 29.57 26.39 27.15 0.00 0.00 0.00
Dividend Yield
1.26% 1.38% 1.45% 1.53% 1.05% 0.94% 1.00% 0.94% 1.05% 1.01% 0.96%
Earnings Yield
5.40% 5.51% 5.12% 5.62% 4.19% 3.38% 3.79% 3.68% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
3.16 2.88 3.30 3.84 4.35 4.93 4.89 6.69 4.31 4.62 5.19
Enterprise Value to Revenue (EV/Rev)
1.39 1.27 1.15 1.02 1.66 1.92 1.75 1.80 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
9.84 9.37 9.06 7.80 12.08 14.89 12.97 12.72 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
14.23 13.66 13.60 11.40 17.05 21.51 18.28 17.55 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
19.73 18.27 17.51 15.10 22.76 28.93 24.67 24.89 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
48.85 19.85 11.67 10.64 15.87 19.65 38.60 24.93 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
134.86 29.55 14.23 11.51 16.79 21.71 58.96 40.02 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.51 0.39 0.15 0.00 0.33 0.45 0.29 0.00 0.37 0.61 0.47
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
0.20 0.30 0.06 -0.18 0.24 0.32 0.10 -0.17 0.26 0.51 0.36
Leverage Ratio
2.74 2.74 2.68 2.61 2.73 2.78 2.72 2.65 2.60 3.08 3.12
Compound Leverage Factor
2.62 2.45 2.44 2.51 2.66 2.41 2.49 2.53 2.55 2.79 2.82
Debt to Total Capital
33.69% 28.29% 13.34% 0.00% 24.84% 31.21% 22.68% 0.00% 27.22% 37.85% 32.02%
Short-Term Debt to Total Capital
33.69% 28.29% 13.34% 0.00% 24.84% 31.21% 22.68% 0.00% 27.22% 37.85% 32.02%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
66.31% 71.71% 86.66% 100.00% 75.16% 68.79% 77.32% 100.00% 72.78% 62.15% 67.98%
Debt to EBITDA
1.19 0.97 0.41 0.00 0.79 1.03 0.66 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.77 0.80 0.06 0.00 0.37 0.74 0.39 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
2.39 1.89 0.80 0.00 1.50 2.01 1.26 0.00 0.00 0.00 0.00
Net Debt to NOPAT
1.54 1.55 0.11 0.00 0.70 1.44 0.75 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
2.92 2.99 3.09 3.06 3.75 3.85 3.61 4.04 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.02 1.07 1.11 1.12 1.16 1.07 1.06 1.07 1.03 0.92 0.90
Quick Ratio
0.97 1.00 1.03 1.08 1.10 1.01 1.00 1.01 0.96 0.86 0.85
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-26 -5.03 18 26 31 22 -15 -3.95 0.00 0.00 0.00
Operating Cash Flow to CapEx
-12,464.59% 704.44% 8,946.56% 16,787.43% -8,641.10% 78.02% 1,057.74% 749.92% -8,212.94% 492.18% 5,622.62%
Free Cash Flow to Firm to Interest Expense
-45.61 -3.12 17.60 43.03 66.22 14.90 -9.99 -3.90 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
-122.68 3.14 63.37 100.17 -135.95 1.22 21.68 78.40 -186.47 3.26 20.88
Operating Cash Flow Less CapEx to Interest Expense
-123.67 2.69 62.66 99.57 -137.52 -0.34 19.63 67.95 -188.74 2.60 20.51
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.07 1.11 1.11 1.13 1.15 1.19 1.20 1.22 0.00 0.00 0.00
Accounts Receivable Turnover
3.21 2.95 3.02 3.16 3.16 3.04 3.16 3.28 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
12.46 13.26 13.97 14.90 15.96 16.46 17.15 16.49 0.00 0.00 0.00
Accounts Payable Turnover
24.03 26.31 24.85 15.63 16.04 1.00 1.22 16.88 0.00 0.00 0.00
Days Sales Outstanding (DSO)
113.69 123.86 120.85 115.40 115.40 120.19 115.64 111.27 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
15.19 13.87 14.69 23.36 22.75 363.67 299.97 21.62 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
98.50 109.99 106.16 92.04 92.65 -243.48 -184.33 89.65 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
261 269 212 167 245 254 240 185 287 298 274
Invested Capital Turnover
2.45 2.34 2.80 3.60 2.54 2.50 2.97 3.91 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital
36 16 -9.23 -13 -17 -14 28 19 0.00 0.00 0.00
Enterprise Value (EV)
826 773 701 639 1,064 1,253 1,174 1,240 1,237 1,374 1,423
Market Capitalization
761 707 697 685 1,031 1,191 1,138 1,267 1,178 1,273 1,351
Book Value per Share
$27.40 $28.86 $29.70 $30.29 $30.41 $27.73 $30.17 $31.28 $33.47 $28.93 $30.63
Tangible Book Value per Share
$13.22 $14.38 $15.27 $15.84 $15.95 $13.00 $15.09 $16.39 $18.60 $14.04 $15.33
Total Capital
297 283 240 212 282 279 265 212 312 317 297
Total Debt
100 80 32 0.00 70 87 60 0.00 85 120 95
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
64 66 4.40 -46 33 62 36 -27 59 101 73
Capital Expenditures (CapEx)
0.56 0.72 0.73 0.36 0.73 2.32 2.99 11 0.97 1.19 0.65
Debt-free, Cash-free Net Working Capital (DFCFNWC)
69 81 29 -16 72 81 53 -8.66 67 76 39
Debt-free Net Working Capital (DFNWC)
105 96 56 29 109 106 77 18 93 96 62
Net Working Capital (NWC)
4.51 16 24 29 39 19 17 18 7.62 -24 -33
Net Nonoperating Expense (NNE)
0.78 1.61 0.22 1.17 0.44 1.14 1.68 -0.09 0.66 1.85 0.70
Net Nonoperating Obligations (NNO)
64 66 4.40 -46 33 62 36 -27 59 101 73
Total Depreciation and Amortization (D&A)
6.51 6.50 6.36 6.47 6.36 6.71 6.75 7.01 7.26 7.43 7.38
Debt-free, Cash-free Net Working Capital to Revenue
11.59% 13.39% 4.75% -2.60% 11.13% 12.39% 7.85% -1.26% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue
17.55% 15.74% 9.30% 4.71% 16.90% 16.17% 11.49% 2.63% 0.00% 0.00% 0.00%
Net Working Capital to Revenue
0.76% 2.59% 4.03% 4.71% 6.01% 2.84% 2.57% 2.63% 0.00% 0.00% 0.00%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $1.22 $1.65 $1.97 $0.96 $1.68 $2.21 $2.65 $1.81 $1.74
Adjusted Weighted Average Basic Shares Outstanding
7.12M 6.98M 6.98M 7.01M 6.93M 6.83M 6.76M 6.82M 6.78M 6.69M 6.56M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $1.21 $1.61 $1.95 $0.94 $1.67 $2.18 $2.62 $1.79 $1.73
Adjusted Weighted Average Diluted Shares Outstanding
7.25M 7.08M 7.08M 7.12M 7.01M 6.91M 6.84M 6.91M 6.86M 6.75M 6.62M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
7.03M 7.00M 7.00M 6.96M 6.92M 6.78M 6.78M 6.79M 6.81M 6.58M 6.56M
Normalized Net Operating Profit after Tax (NOPAT)
9.70 11 8.82 13 14 7.68 13 15 19 14 12
Normalized NOPAT Margin
6.34% 6.86% 5.98% 7.81% 8.22% 4.48% 7.82% 8.44% 10.26% 7.48% 6.55%
Pre Tax Income Margin
8.24% 8.40% 7.13% 9.63% 11.07% 5.61% 9.56% 12.23% 13.55% 9.16% 8.73%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
23.06 9.42 11.27 26.93 41.97 7.48 12.00 22.31 58.45 10.53 10.27
NOPAT to Interest Expense
16.98 6.88 8.60 21.05 30.45 5.18 9.01 14.70 43.50 7.78 6.95
EBIT Less CapEx to Interest Expense
22.07 8.98 10.56 26.34 40.40 5.92 9.95 11.85 56.18 9.87 9.90
NOPAT Less CapEx to Interest Expense
16.00 6.43 7.89 20.45 28.87 3.61 6.96 4.25 41.23 7.12 6.58
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
24.09% 26.10% 29.40% 28.08% 25.85% 28.68% 27.56% 26.36% 0.00% 0.00% 0.00%
Augmented Payout Ratio
129.30% 99.42% 95.45% 109.73% 72.28% 130.92% 123.07% 97.85% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Charles River Associates (NASDAQ: CRAI) showed a solid revenue and earnings recovery in 2025-2026, but its balance sheet remains more leveraged and working-capital intensive than it was a year earlier. Across the last several quarters, the company has kept revenue fairly steady around the high-$100 million to low-$200 million range, while profitability improved meaningfully versus late 2024 and early 2025. At the same time, the company used substantial debt and buybacks, which helped shareholders but also left short-term debt elevated.

  • Revenue held up well and improved year over year. Q3 2026 revenue was $185.9 million, up from $167.7 million in Q3 2024 and above the prior-quarter levels seen in 2026.
  • Profitability improved versus the weaker periods in late 2024 and early 2025. Q3 2026 net income was $11.5 million, and Q2 2026 net income was $12.1 million, both above Q2 2024’s $6.5 million.
  • Operating margins recovered meaningfully. Q3 2026 operating income of $17.2 million was a strong result relative to revenue, and Q2 2026 operating income of $19.7 million also looked healthy.
  • Gross profit remained resilient. In Q2 and Q3 2026, gross profit stayed in the mid-$50 million range, indicating the business continues to convert revenue into profit efficiently.
  • Earnings per share trended higher. Diluted EPS was $1.79 in Q2 2026 and $1.73 in Q3 2026, versus $0.94 in Q2 2024 and $1.21 in Q3 2024.
  • Operating cash flow turned strong in Q3 2026. Net cash from operations was $36.5 million in Q3 2026, a big rebound from $5.9 million in Q2 2026 and a reversal from the very weak Q1 2026 period.
  • Cash on hand increased in Q3 2026. Cash and equivalents rose to $22.5 million from $19.4 million in Q2 2026.
  • Share count has been managed, but dilution is still visible. Basic shares were 6.56 million in Q3 2026, down from 6.70 million in Q2 2026, while diluted shares remained around 6.62 million to 6.75 million.
  • Capital spending appears modest. Q3 2026 capex was only $0.7 million, suggesting the company is not making heavy near-term investment demands on cash.
  • Liquidity looks tight relative to current obligations. At Q3 2026, current liabilities were $338.6 million versus current assets of $305.6 million, implying a working-capital deficit on the balance sheet.
  • Short-term debt remains high. CRAI had $95.0 million of short-term debt in Q3 2026, down from $120.0 million in Q2 2026, but still a meaningful obligation.
  • Accrued expenses are large and grew materially over the period. Accrued expenses were $182.7 million in Q3 2026, a major portion of current liabilities and a factor investors should watch closely.
  • Operating cash flow was volatile earlier in the year. Q1 2026 operating cash flow was negative $80.0 million, showing that earnings conversion can swing sharply quarter to quarter.
  • Financing activity has relied heavily on debt. The company issued $90.0 million of debt in Q1 2026 and $42.0 million in Q2 2026, while continuing to repay debt and return cash to shareholders.

Bottom line: CRAI’s recent results point to improving profitability and a decent rebound in cash generation, which is encouraging for a consulting firm with relatively stable revenue. However, the balance sheet is still burdened by sizable short-term debt and current liabilities, so investors should watch whether operating cash flow stays strong enough to support the company’s capital structure and ongoing shareholder returns.

06/09/26 04:09 AM ETAI Generated. May Contain Errors.

Charles River Associates Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Charles River Associates' fiscal year ends in January. Their fiscal year 2026 ended on January 3, 2026.

Charles River Associates' net income appears to be on an upward trend, with a most recent value of $54.78 million in 2025, rising from $6.33 million in 2015. The previous period was $46.65 million in 2024. Check out Charles River Associates' forecast to explore projected trends and price targets.

Charles River Associates' total operating income in 2025 was $83.12 million, based on the following breakdown:
  • Total Gross Profit: $751.58 million
  • Total Operating Expenses: $668.46 million

Over the last 10 years, Charles River Associates' total revenue changed from $303.56 million in 2015 to $751.58 million in 2025, a change of 147.6%.

Charles River Associates' total liabilities were at $415.28 million at the end of 2025, a 15.6% increase from 2024, and a 304.6% increase since 2015.

In the past 10 years, Charles River Associates' cash and equivalents has ranged from $18.21 million in 2025 to $66.13 million in 2021, and is currently $18.21 million as of their latest financial filing in 2025.

Over the last 10 years, Charles River Associates' book value per share changed from 23.61 in 2015 to 32.55 in 2025, a change of 37.9%.



Financial statements for NASDAQ:CRAI last updated on 3/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners